Ciprofibrate (CAS 52214-84-3), a cardiovascular system drug used for lipid management, is manufactured directly by Jiangsu Nhwa Pharmaceutical Co., Ltd. to ChP, USP, and EP standards in pharmaceutical grade. It is distributed into North America and Asia.
평가 & 댓글 남기기